Discover 482 paid clinical trials in Rhode Island. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Rhode Island offers a variety of research opportunities for healthy individuals looking to volunteer in paid studies and those with specific health conditions alike. Research centers in Providence, Warwick, and Cranston are actively recruiting participants, providing access to advanced treatments and top-tier healthcare.
Filter
1
Filter results
Results: 482
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
for
Irritable Bowel Syndrome, Constipation
Location: Providence RI, New York NY, Hollywood FL, Scarborough,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07545772
Phase2, Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
for
Irritable Bowel Syndrome, Diarrhea
Location: Providence RI, Hollywood FL, Scarborough, Stouffville,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07545759
Phase2, Recruiting
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Boston MA, Providence RI, New York NY, Fairfax VA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase2, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Boston MA, Providence RI, New Haven CT, Lake Success NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase3, Recruiting
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
for
Type 2 Diabetes
Location: East Greenwich RI, Burke VA, Midlothian VA, Miami FL,
Sponsor: Housey Healthcare ULC
Sex: All
Age: 18+
Code: NCT07546929
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Rhode Island Community-based Maternal Support Services
for
Perinatal Outcomes, Social Determinants of Health (SDOH),
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island
Sex: Female
Age: 0+
Code: NCT07446374
Recruiting
Pilot Trial of Supplemental Vitamin A and Nicotinamide
for
Skin Cancer, Kidney Transplant Recipients
Location: Providence RI
Sponsor: Rhode Island Hospital
Sex: All
Age: 18+
Code: NCT05702398
Early_phase1, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Scarborough ME, Providence RI, Chicoutimi, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase3, Recruiting
Cognitive Rehabilitation for Veterans With PNES
for
Psychogenic Nonepileptic Seizures (PNES)
Location: Providence RI
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT07316543
Recruiting
Adolescent Stress and Substance Intervention Subsequent to Trauma
for
PTSD, Substance Use Disorder (SUD), Acute Stress Disorder
Location: Providence RI
Sponsor: Rhode Island Hospital
Sex: All
Age: 12 - 17
Code: NCT07197476
Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
for
Fibromyalgia
Location: Boston MA, Watertown MA, Cranston RI, Cromwell CT,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07398417
Phase3, Recruiting
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: Westerly RI, Waterford CT, Guilford CT, North Haven CT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase2, Phase3, Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase3, Recruiting
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
for
Obesity With Diabetes, Overweight With Diabetes
Location: Boston MA, East Greenwich RI, Stamford CT, Laurelton NY,
Sponsor: Kailera
Sex: All
Age: 18+
Code: NCT07284901
Phase3, Recruiting
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
for
Obesity
Location: East Greenwich RI, Hamden CT, Stamford CT, Albany NY,
Sponsor: Kailera
Sex: All
Age: 18+
Code: NCT07284979
Phase3, Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Halifax, Providence RI, New Haven CT, Quebec,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase3, Recruiting
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Portland ME, Boston MA, Providence RI, Stamford CT,